Beneficient granted listing extension by Nasdaq

Beneficient (BENF) was notified by The Nasdaq Stock Market that the Nasdaq Hearings Panel had granted the Company’s request for continued listing on Nasdaq, subject to the Company evidencing compliance with Nasdaq’s periodic reporting requirement by filing its Annual Report on Form 10-K for the fiscal year ended March 31, 2025, and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, with the Securities and Exchange Commission, and demonstrating compliance with the $1.00 per share bid price requirement within the extension period granted by the Panel. The Company continues to work diligently with its auditor to complete and file the Delayed Reports and expects to do so within the extension period granted by the Panel. Additionally, to the extent to Company has not regained compliance with the bid price requirement, the Company plans to seek stockholder approval to effect a reverse stock split of its common stock, which the Company anticipates will allow it to demonstrate compliance with the $1.00 bid price requirement for the requisite minimum 10-consecutive trading day period within the extension granted by the Panel.